{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:41:09Z","timestamp":1789382469514,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T00:00:00Z","timestamp":1589760000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.04.038","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T01:25:45Z","timestamp":1590197145000},"page":"7393-7400","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Shengli","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1495-5521","authenticated-orcid":false,"given":"Jialiang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-285X","authenticated-orcid":false,"given":"Qingchuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiamei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianli","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2020.04.038_b0005","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/civ1013","article-title":"Parashar UD, WHO coordinated Global Rotavirus Surveillance Network. Global, regional, and national estimates of rotavirus mortality in children <5 Years of Age, 2000\u20132013","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.038_b0010","first-page":"29","article-title":"The global problem of childhood diarrhoeal diseases: emerging strategies in prevention and management","volume":"5","author":"Mokomane","year":"2018","journal-title":"Ther Adv Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.04.038_b0015","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.vaccine.2011.12.092","article-title":"Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review","volume":"30","author":"Kawai","year":"2012","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.04.038_b0020","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1097\/INF.0000000000001327","article-title":"The public health burden of rotavirus disease in children younger than five years and considerations for rotavirus vaccine introduction in China","volume":"35","author":"Wu","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2020.04.038_b0025","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1469-0691.2012.03981.x","article-title":"Rotavirus vaccination: a concise review","volume":"18","author":"Vesikari","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2020.04.038_b0030","first-page":"CD008521","article-title":"Vaccines for preventing rotavirus diarrhoea: vaccines in use","volume":"11","author":"Soares-Weiser","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.vaccine.2020.04.038_b0035","first-page":"e64","article-title":"Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design","volume":"4","author":"Zhen","year":"2015","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2020.04.038_b0040","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1016\/j.vaccine.2007.10.036","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study","volume":"25","author":"Fu","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.038_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/hv.26319","article-title":"Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China","volume":"10","author":"Li","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"43","key":"10.1016\/j.vaccine.2020.04.038_b0050","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.1016\/j.vaccine.2017.08.081","article-title":"Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: a randomized, double-blind, placebo-controlled trial","volume":"35","author":"Mo","year":"2017","journal-title":"Vaccine"},{"issue":"35","key":"10.1016\/j.vaccine.2020.04.038_b0055","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.1016\/j.vaccine.2014.06.018","article-title":"Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis","volume":"32","author":"Liu","year":"2014","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.038_b0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jinf.2018.07.004","article-title":"Prevalence of rotavirus and rapid changes in circulating rotavirus strains among children with acute diarrhea in China, 2009\u20132015","volume":"78","author":"Yu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.vaccine.2020.04.038_b0065","unstructured":"Zhao JY, Shen XJ, Xia SL, Zhang BF, Mu YJ, Huang XY, Xu BL. Infection status, clinical symptoms and gene type transition of group A rotavirus in children, less than five years-of-age, with diarrhea in sentinel hospitals of Henan Province, China. Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Jan 6;51(1):82\u201386. Article in Chinese."},{"issue":"3","key":"10.1016\/j.vaccine.2020.04.038_b0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3109\/00365549009027046","article-title":"Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes","volume":"22","author":"Ruuska","year":"1990","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.038_b0075","unstructured":"http:\/\/www.sda.gov.cn\/WS01\/CL1616\/83435.html. [in Chinese]."},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.038_b0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/cit164","article-title":"Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009\u20132011","volume":"57","author":"Payne","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.04.038_b0085","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1086\/649843","article-title":"Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil","volume":"201","author":"Correia","year":"2010","journal-title":"J Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.04.038_b0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1590\/S0074-02762012000700002","article-title":"Oral live attenuated human rotavirus vaccine (Rotarix\u2122) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children","volume":"107","author":"Justino","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"10.1016\/j.vaccine.2020.04.038_b0095","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.inf.0000178294.13954.a1","article-title":"Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants","volume":"24","author":"Salinas","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.038_b0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.vaccine.2019.09.088","article-title":"The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: a double-blind, parallel group, randomized, controlled trial","volume":"38","author":"Lee","year":"2020","journal-title":"Vaccine"},{"issue":"31","key":"10.1016\/j.vaccine.2020.04.038_b0105","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1016\/j.vaccine.2019.05.069","article-title":"A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC\u00ae in comparison with a licensed rotavirus vaccine in healthy infants","volume":"37","author":"Ella","year":"2019","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2020.04.038_b0110","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.vaccine.2019.03.067","article-title":"Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL-Liquid) in Indian infants","volume":"37","author":"Kawade","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.04.038_b0115","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.4161\/hv.34361","article-title":"Correlates of protection for rotavirus vaccines: Possible alternative trial endpoints, opportunities, and challenges","volume":"10","author":"Angel","year":"2014","journal-title":"Hum Vaccin Immunother."},{"issue":"3","key":"10.1016\/j.vaccine.2020.04.038_b0120","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s40272-018-0283-3","article-title":"Rotavirus vaccines: effectiveness, safety, and future directions","volume":"20","author":"Burnett","year":"2018","journal-title":"Paediatr Drugs"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:02Z","timestamp":1759402022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":24,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20305314"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.038","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: A randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}